The ASISA Group trusts Atos with workplace modernization for its more than 6,000 employees
September 13, 2023 04:00 ET
|
Atos International
Madrid, 13th September, 2023 - The ASISA Group, the Spanish’ leading healthcare private group, has entrusted Atos with the modernization and management of its digital workplace services, care and...
Pupillometer Market to hit USD 706 million by 2032, says Global Market Insights Inc.
September 12, 2023 20:15 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Pupillometer Market size is expected to be worth USD 706 million by 2032. Surging importance in research studies and clinical trials for...
Sensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of Directors
September 12, 2023 08:00 ET
|
Sensorium Therapeutics
BOSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Sensorium Therapeutics (Sensorium), a biotechnology company translating insights from nature and human experience to deliver transformational therapeutics,...
Biomaterials Market Anticipated to Achieve USD 540.5 Billion by 2032 || Recording a CAGR of 13.6%
September 11, 2023 08:11 ET
|
Market.Us
New York, Sept. 11, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the Global Biomaterials Market Size accounted for USD 155.9 Billion in 2022 and is estimated to garner a market size of USD 540.5...
Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases
September 07, 2023 17:00 ET
|
Shape Therapeutics, Inc.; Otsuka
TOKYO and SEATTLE, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Otsuka Pharmaceutical Co., Ltd. (Otsuka) and ShapeTX, the programmable medicine company using AI and RNA to end genetic diseases, today announce...
Cognition Therapeutics Announces New Conversations Episode on Therapeutic Strategies to Protect the Retina in Dry AMD
September 07, 2023 07:45 ET
|
Cognition Therapeutics, Inc.
PURCHASE, N.Y., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”) has released its sixth “Conversations” video podcast, which features...
Placental Growth Factors Market Growth 2023 along with Business Insights and Forecast to 2033
September 06, 2023 11:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 06, 2023 (GLOBE NEWSWIRE) -- In 2023, the placental growth factors market is expected to be worth US$ 34.9 million. The market is expected to reach US$ 64.6 million by 2033,...
Kriya Acquires Tramontane Therapeutics and Launches Gene Therapy Program for Nonalcoholic Steatohepatitis (NASH) and Other Prevalent Diseases
September 06, 2023 08:30 ET
|
Kriya Therapeutics, Inc.
– Kriya envisions treating people with NASH using a one-time intramuscular gene therapy enabling continuous expression of native FGF21 – – Kriya anticipates advancing its NASH gene therapy candidate...
With Little Remaining Unmet Need for Injectable Biologics for the Treatment of Plaque Psoriasis, US Dermatologists Report the Future is Oral, According to Spherix Global Insights
August 31, 2023 16:35 ET
|
Spherix Global Insights
Exton, Pennsylvania, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The biologic treatment armamentarium for plaque psoriasis has arguably experienced some of the most successful developments in recent...
LUMIBIRD COMPLETES ACQUISITION OF PRIMA INDUSTRIE'S HIGH POWER LASER AND SEMICONDUCTOR BUSINESSES IN ITALY AND THE UNITED STATES
August 31, 2023 11:35 ET
|
Lumibird SA
Lannion, 31/08/2023 – 5:35 pm LUMIBIRD COMPLETES ACQUISITION OF PRIMA INDUSTRIE'S HIGH POWER LASER AND SEMICONDUCTOR BUSINESSES IN ITALY AND THE UNITED STATES The LUMIBIRD Group (FR0000038242 -...